Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Abatacept plus MMF vs placebo in lupus nephritis (China, phase 3)
CTR20140843Phase 3Active
- Sponsor
- Bristol Myers Squibb
- Start
- Jan 2015
- Modality
- Fc-Fusion Proteins → Carrier/Scaffold Proteins → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of abatacept in lupus nephritis (LN), sponsored by Bristol Myers Squibb. Started Jan 2015; status: active.
02
Drugs
abatacept
03
Conditions
lupus nephritis (LN)
Beyond the preview
Go deeper on CTR20140843.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20140843.